Arie Belldegrun
Co-Founder and Senior Managing Director
Vida Ventures, LLC
Arie Belldegrun, MD is co-founder and senior managing director of Vida Ventures. He previously founded Kite Pharma, where he served as chairman, president, and chief executive officer of Kite until its acquisition in October 2017 by Gilead Sciences for $11.9 billion, the industry’s largest ever pre-commercial acquisition.
As a surgeon, entrepreneur and visionary, Dr. Belldegrun founded Vida to build upon Kite’s cancer-fighting success, create more opportunities like CAR T, and convert cutting-edge science into groundbreaking therapies for patients. Vida, a next-generation life sciences venture firm based in Los Angeles, now has approximately $2 billion in assets under management. Under Dr. Belldegrun’s leadership, Vida has established its approach to life sciences investing by bringing together a network of industry experts alongside a powerful investor base undaunted by inherent challenges in drug development, with the goal of fundamentally changing the course of human disease.
